Clinical Study on Dominant Diseases of Aplastic Anemia in Traditional Chinese Medicine-Exploration and Application Based on Intelligent Diagnosis and Treatment Equipment

Not Applicable

• Conditions: Aplastic Anemia

• Registration Number: ITMCTR2024000084
• Lead Sponsor: The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1) Meet the diagnostic criteria for aplastic anaemia;
2) The patient's age range is 16 to 80 years old;
3) No standard regimen has been used for treatment after the first diagnosis, or the current regimen has been maintained for more than 3 months;
4) Sound liver and kidney function (creatinine ?1.5*ULN, BUN ?1.5*ULN, ALT ?2*ULN, AST ?2*ULN, total bilirubin ?1.5*ULN);
5) Able to comply with the study visit schedule and understand and comply with all trial protocol requirements;
6) Able to understand and voluntarily sign the written informed consent.

Exclusion Criteria

1) Combination of PNH clones;
2) Allergy to herbal medicinal tablets;
3) Severe cardiac disease, including New York Heart Association (NYHA) class III or IV congestive heart failure, uncontrolled hypertension or hypotension, or severe valvular or endocardial disease resulting in a risk of thromboembolism in the subject;
4) Clinically significant or uncontrolled persistent inflammatory/autoimmune disease (e.g., rheumatoid arthritis, Crohn's disease, ulcerative colitis, celiac disease, systemic lupus erythematosus, etc.);
5) Anticipated haematopoietic stem cell transplantation within 3 months.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified